[1] Bakker MK, van Straten T, Chong M, et al. Anti-Epileptic Drug Target Perturbation and Intracranial Aneurysm Risk: Mendelian Randomization and Colocalization Study[J]. Stroke,2023,54(1):208-216.
[2] Maimaiti A, Turhon M, Abulaiti A, et al.DNA methylation regulator-mediated modification patterns and risk of intracranial aneurysm: a multi-omics and epigenome-wide association study integrating machine learning, Mendelian randomization, eQTL and mQTL data[J]. J Transl Med,2023,21(1):660.
[3] 许斌,刘耀,白卫星,等.Surpass Streamline血流导向装置治疗颅内动脉瘤的初步分析[J].中华神经外科杂志,2023,39(7):669-673.
[4] 沈寻,王文蕾,秦怀海,等.Neuroform EZ支架辅助颅内动脉瘤栓塞后动脉内膜增生的动态演化规律[J].介入放射学杂志,2023,32(1):48-54.
[5] 马春红,张玲霞.多学科协作模式护理对颅内动脉瘤弹簧圈栓塞手术患者生活质量及精神状态的影响[J].中国医药导报,2022,19(4):186-189.
[6] 张化彪,张晓燕,郑国墩,等.支架置入方案在单支架辅助弹簧圈栓塞颅内分叉处宽颈动脉瘤中的应用效果[J].中华神经外科杂志,2024,40(7):664-669.
[7] 中华医学会神经外科学分会神经介入学组.颅内动脉瘤血管内介入治疗中国专家共识(2013)[J].中华医学杂志,2013,93(39):3093-3103.
[8] Chen B, Xie K, Zhang J, et al.Comprehensive analysis of mitochondrial dysfunction and necroptosis in intracranial aneurysms from the perspective of predictive, preventative, and personalized medicine[J]. Apoptosis,2023,28(9-10):1452-1468.
[9] 曾明礼,陈绍华,王瑶,等.急性缺血性脑卒中合并未破裂颅内动脉瘤病人早期介入栓塞治疗与预后的关系[J].中西医结合心脑血管病杂志,2023,21(3):544-547.
[10] Hanel RA, Cortez GM, Lopes DK, et al.Prospective study on embolization of intracranial aneurysms with the pipeline device (PREMIER study): 3-year results with the application of a flow diverter specific occlusion classification[J]. J Neurointerv Surg,2023,15(3):248-254.
[11] Guo T, Cui Z, Li J.Early vascular embolization improves neurological function in patients with intracranial aneurysm[J]. Am J Transl Res,2024,16(4):1273-1280.
[12] 詹世钦,赵万里,覃波.颅内动脉瘤支架联合弹簧圈栓塞术后差异性双联抗血小板维持时间对迟发性脑缺血的作用效果比较[J].生物医学工程与临床,2023,27(2):201-205.
[13] 杜战锋,严亿军,崔旭波,等.两种不同支架辅助弹簧圈栓塞治疗颅内动脉瘤的临床效果及对远期预后的影响[J].海南医学,2023,34(7):949-952.
[14] 尹淼,黄志强,朱杰.S-100b蛋白、可溶性白介素-2受体水平与颅内感染合并脑梗死的相关性及预后预测价值[J].临床和实验医学杂志,2023,22(10):1026-1030.
[15] 马琳,王樑,赵彬芳,等.颅脑外伤患者围手术期Trx1、NGF、hs-CRP动态变化对预后的预测效能探讨[J].中国急救复苏与灾害医学杂志,2023,18(1):55-58. |
